Management of Aorto-iliac Infection With BioIntegral Surgical No-React® Bovine Pericardial Xenografts

ConditionAortic Diseases

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorFondazione Policlinico Universitario Agostino Gemelli IRCCS

About this trial

Aortic infections (AIs), including aortic graft infections (AGI) as well as mycotic aortic aneurysms (MAA), are rare. The aim of this study is to present our experience with xenogeneic aortic and aortoiliac reconstructions using the BioIntegral Surgical No-React® bovine pericardial graft.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Aortic infection

Mycotic Aneurysm

Aortic Graft Infection

Disqualifiers

Absence of signs of infection

Trial population

All consecutive patients who underwent replacement of an infected aneurysm or graft with a BioIntegral Surgical No-React® bovine pericardial prosthesis at our Institution.

Trial design

Design model

Cohort

Time perspective

Retrospective

Treatments tested in this trial

Aortic Surgery
Procedure/Surgery
open surgical repair with resection of infected aortic segment, debridement of surrounding tissue and in situ graft replacement.

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

Early Mortality

Mortality 30 days after the procedure

Time frame

30 days

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Lead sponsor

Source ClinicalTrials.gov

Apply now